mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.5 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
AZD-7545 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.031 |
0.6 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.6 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |